Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications"

B. Godman, M. Wladysiuk, S. McTaggart, A. Kurdi, E. Allocati, M. Jakovljevic, F. Kalemeera, I. Hoxha, A. Nachtnebel, R. Sauermann, M. Hinteregger, V. Marković-Peković, B. Tubic, G. Petrova, K. Tachkov, J. Slabý, R. Nejezchlebova, IS. Krulichová,...

. 2023 ; 2023 (-) : 9757348. [pub] 20230407

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu tisková chyba

Perzistentní odkaz   https://www.medvik.cz/link/bmc23010035

[This corrects the article DOI: 10.1155/2021/9996193.].

Agency for Medicinal Product and Medical Devices of Bosnia and Herzegovina 78000 Banja Luka Bosnia and Herzegovina

Centre for Primary Care and Health Services Research School of Health Sciences University of Manchester Manchester M13 9PL UK

Chair of Epidemiology and Preventive Medicine Medical College Jagiellonian University Krakow Poland

Dachverband der Österreichischen Sozialversicherungen Kundmanngasse 21 AT 1030 Vienna Austria

Department of Global Health Economics and Policy University of Kragujevac Serbia

Department of Global Public Health Karolinska Institutet Stockholm Sweden

Department of Health Policy and Health Economics Eotvos Lorand University Budapest Hungary

Department of Health Services Management University of Malta Valletta Malta

Department of Medical Biophysics Faculty of Medicine in Hradec Králové Charles University Simkova 870 500 03 Hradec Králové Czech Republic

Department of Pathology Forensic Medicine and Pharmacology Institute of Biomedical Sciences Faculty of Medicine Vilnius University Vilnius Lithuania

Department of Pharmacology College of Pharmacy Hawler Medical University Erbil Iraq

Department of Pharmacology Therapeutics and Toxicology Universitat Autònoma de Barcelona Barcelona Spain

Department of Pharmacy Disciplinary Domain of Medicine and Pharmacy Uppsala University Uppsala Sweden

Department of Pharmacy Faculty of Medicine University of Medicine Tirana Albania

Department of Pharmacy Practice and Policy Faculty of Health Sciences University of Namibia Windhoek Namibia

Division of Public Health Pharmacy and Management School of Pharmacy Sefako Makgatho Health Sciences University Pretoria South Africa

Drug Department Catalan Health Service Gran Via de les Corts Catalanes 08007 Barcelona Spain

Faculty of Medicine Department of Medicinal Chemistry University of Banja Luka Banja Luka Bosnia and Herzegovina

Faculty of Medicine Department of Social Pharmacy University of Banja Luka Banja Luka Bosnia and Herzegovina

Faculty of Medicine Public Health and Management Department Carol Davila University of Medicine and Pharmacy Bucharest 050463 Bucharest Romania

Faculty of Pharmacy Department of Social Pharmacy and Pharmacoeconomics Medical University of Sofia Sofia Bulgaria

Faculty of Pharmacy UBT Higher Education Institute Pristina Kosovo

Health Insurance Institute Miklosiceva 24 SI 1507 Ljubljana Slovenia

HTA Consulting Starowiślna Str 17 3 31 038 Krakow Poland

Independent Consultant Riga Latvia

Institute of Advanced Manufacturing Technologies Peter the Great St Petersburg Polytechnic University St Petersburg Russia

Institute of Comparative Economic Studies Hosei University Tokyo Japan

Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy

Medicines Committee Oslo University Hospitals Oslo Norway

National Organization for the Provision of Healthcare Services Athens Greece

NEPI Nätverk för Läkemedelsepidemiologi Stockholm Sweden

NHS Lothian Edinburgh UK

NIHR Greater Manchester Patient Safety Translational Research Centre School of Health Sciences University of Manchester Manchester UK

Pharmacy Services Greater Glasgow and Clyde Glasgow UK

Public Health Scotland Gyle Square 1 South Gyle Crescent Edinburgh UK

School of Pharmaceutical Sciences Universiti Sains Malaysia Penang Malaysia

State Agency of Medicines Nooruse 1 50411 Tartu Estonia

State Institute for Drug Control Prague Czech Republic

Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow G4 0RE UK

Syreon Research Institute and Semmelweis University Center of Health Technology Assessment Budapest Hungary

Wissenschaftliches Institut der AOK Rosenthaler Straße 31 10178 Berlin Germany

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23010035
003      
CZ-PrNML
005      
20230721095343.0
007      
ta
008      
230707s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2023/9757348 $2 doi
035    __
$a (PubMed)37065720
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Godman, Brian $u Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK $u Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa $u School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
245    10
$a Corrigendum to "Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications" / $c B. Godman, M. Wladysiuk, S. McTaggart, A. Kurdi, E. Allocati, M. Jakovljevic, F. Kalemeera, I. Hoxha, A. Nachtnebel, R. Sauermann, M. Hinteregger, V. Marković-Peković, B. Tubic, G. Petrova, K. Tachkov, J. Slabý, R. Nejezchlebova, IS. Krulichová, O. Laius, G. Selke, I. Langner, A. Harsanyi, A. Inotai, A. Jakupi, S. Henkuzens, K. Garuolienė, J. Gulbinovič, PV. Bonanno, J. Rutkowski, S. Ingeberg, Ø. Melien, I. Mardare, J. Fürst, S. MacBride-Stewart, C. Holmes, C. Pontes, C. Zara, MT. Pedrola, M. Hoffmann, V. Kourafalos, A. Pisana, R. Banzi, S. Campbell, B. Wettermark
520    9_
$a [This corrects the article DOI: 10.1155/2021/9996193.].
590    __
$a NEINDEXOVÁNO
655    _2
$a tisková chyba $7 D016425
700    1_
$a Wladysiuk, Magdalene $u Chair of Epidemiology and Preventive Medicine, Medical College, Jagiellonian University, Krakow, Poland $u HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland
700    1_
$a McTaggart, Stuart $u Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, UK
700    1_
$a Kurdi, Amanj $u Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK $u Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa $u Department of Pharmacology, College of Pharmacy, Hawler Medical University, Erbil, Iraq
700    1_
$a Allocati, Eleonora $u Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy
700    1_
$a Jakovljevic, Mihajlo $u Institute of Advanced Manufacturing Technologies, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia $u Institute of Comparative Economic Studies, Hosei University Tokyo, Japan $u Department of Global Health Economics and Policy, University of Kragujevac, Serbia $1 https://orcid.org/0000000291606846
700    1_
$a Kalemeera, Francis $u Department of Pharmacy Practice and Policy, Faculty of Health Sciences, University of Namibia, Windhoek, Namibia
700    1_
$a Hoxha, Iris $u Department of Pharmacy, Faculty of Medicine, University of Medicine, Tirana, Albania
700    1_
$a Nachtnebel, Anna $u Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria
700    1_
$a Sauermann, Robert $u Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria
700    1_
$a Hinteregger, Manfred $u Dachverband der Österreichischen Sozialversicherungen, Kundmanngasse 21, AT-1030 Vienna, Austria
700    1_
$a Marković-Peković, Vanda $u Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka, Banja Luka, Bosnia and Herzegovina $1 https://orcid.org/0000000189635720
700    1_
$a Tubic, Biljana $u Faculty of Medicine, Department of Medicinal Chemistry, University of Banja Luka, Banja Luka, Bosnia and Herzegovina $u Agency for Medicinal Product and Medical Devices of Bosnia and Herzegovina, 78000 Banja Luka, Bosnia and Herzegovina
700    1_
$a Petrova, Guenka $u Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria $1 https://orcid.org/0000000181165138
700    1_
$a Tachkov, Konstantin $u Faculty of Pharmacy, Department of Social Pharmacy and Pharmacoeconomics, Medical University of Sofia, Sofia, Bulgaria
700    1_
$a Slabý, Juraj $u State Institute for Drug Control, Prague, Czech Republic
700    1_
$a Nejezchlebova, Radka $u State Institute for Drug Control, Prague, Czech Republic
700    1_
$a Krulichová, Iva Selke $u Department of Medical Biophysics, Faculty of Medicine in Hradec Králové, Charles University, Simkova 870, 500 03 Hradec Králové, Czech Republic
700    1_
$a Laius, Ott $u State Agency of Medicines, Nooruse 1, 50411 Tartu, Estonia
700    1_
$a Selke, Gisbert $u Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany
700    1_
$a Langner, Irene $u Wissenschaftliches Institut der AOK (WIdO), Rosenthaler Straße 31, 10178 Berlin, Germany
700    1_
$a Harsanyi, András $u Department of Health Policy and Health Economics, Eotvos Lorand University, Budapest, Hungary
700    1_
$a Inotai, András $u Syreon Research Institute and Semmelweis University, Center of Health Technology Assessment, Budapest, Hungary $1 https://orcid.org/0000000206632733
700    1_
$a Jakupi, Arianit $u Faculty of Pharmacy, UBT Higher Education Institute, Pristina, Kosovo $1 https://orcid.org/0000000277199690
700    1_
$a Henkuzens, Svens $u Independent Consultant, Riga, Latvia
700    1_
$a Garuolienė, Kristina $u Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania $1 https://orcid.org/0000000179100108
700    1_
$a Gulbinovič, Jolanta $u Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, Vilnius, Lithuania $1 https://orcid.org/0000000337766934
700    1_
$a Bonanno, Patricia Vella $u Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK $u Department of Health Services Management, University of Malta, Valletta, Malta
700    1_
$a Rutkowski, Jakub $u HTA Consulting, Starowiślna Str. 17/3, 31-038 Krakow, Poland
700    1_
$a Ingeberg, Skule $u Medicines Committee, Oslo University Hospitals, Oslo, Norway
700    1_
$a Melien, Øyvind $u Medicines Committee, Oslo University Hospitals, Oslo, Norway
700    1_
$a Mardare, Ileana $u Faculty of Medicine, Public Health and Management Department, "Carol Davila" University of Medicine and Pharmacy Bucharest, 050463 Bucharest, Romania
700    1_
$a Fürst, Jurij $u Health Insurance Institute, Miklosiceva 24, SI-1507 Ljubljana, Slovenia
700    1_
$a MacBride-Stewart, Sean $u Pharmacy Services, Greater Glasgow and Clyde (NHS GGC), Glasgow, UK
700    1_
$a Holmes, Carol $u NHS Lothian, Edinburgh, UK
700    1_
$a Pontes, Caridad $u Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain $u Department of Pharmacology, Therapeutics and Toxicology, Universitat Autònoma de Barcelona, Barcelona, Spain
700    1_
$a Zara, Corinne $u Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain
700    1_
$a Pedrola, Marta Turu $u Drug Department, Catalan Health Service, Gran Via de les Corts Catalanes, 08007 Barcelona, Spain
700    1_
$a Hoffmann, Mikael $u NEPI-Nätverk för Läkemedelsepidemiologi, Stockholm, Sweden
700    1_
$a Kourafalos, Vasileios $u National Organization for the Provision of Healthcare Services (EOPYY), Athens, Greece
700    1_
$a Pisana, Alice $u Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden $1 https://orcid.org/0000000188395171
700    1_
$a Banzi, Rita $u Istituto di Ricerche Farmacologiche "Mario Negri" IRCCS, Milan, Italy $1 https://orcid.org/0000000222113300
700    1_
$a Campbell, Stephen $u Centre for Primary Care and Health Services Research, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK $u NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester, UK $1 https://orcid.org/0000000223284136
700    1_
$a Wettermark, Bjorn $u Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University, Uppsala, Sweden
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2023, č. - (2023), s. 9757348
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37065720 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095336 $b ABA008
999    __
$a ok $b bmc $g 1958610 $s 1196299
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 2023 $c - $d 9757348 $e 20230407 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace